How NK Cell Therapies Are Poised For Breakthroughs In Cancer

In this first segment of our Cell & Gene Live, Building the Future of Cancer Immunotherapy Through Allogeneic NK Cell Innovation, expert panelists, Raphael Ognar, President, CEO, and Co-Founder of NKILT Therapeutics and Tracy Ryan, Co-Founder and Chief Communications Officer of NKore BioTherapeutics, highlighted how natural killer (NK) cell therapies are showing promising results in cancer treatment with compelling patient improvements and safety. Ryan shared personal success stories, including her daughter's recovery, while Ognar noted robust research and the unique advantages of NK cells, especially their potential for scalable, off-the-shelf treatments that could broaden access and reduce costs.